Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinoma.
Tae H HongSoohyun HwangYoon-La ChoiGenehee LeeSehhoon ParkMyung-Ju AhnYoonseo LeeYeong J JeonJunghee LeeSumin ShinSeong Y ParkJong H ChoYong S ChoiJhingook KimYoung M ShimJuhee ChoHong K KimPublished in: Histopathology (2023)
EGFR mutation status was associated with a risk of recurrence after consideration of the IASLC histological grading, especially in G3 tumours. The results of this study would be useful for developing a new staging system and identifying a subset of patients who may benefit from adjuvant targeted therapy.